141 related articles for article (PubMed ID: 20128268)
1. HIV transmission from mother to child--HAART compared with dual therapy.
Theron G; Nellensteijn M; Theron A; Louw J
S Afr Med J; 2009 Oct; 99(10):717, 720. PubMed ID: 20128268
[No Abstract] [Full Text] [Related]
2. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
3. Early outcomes of HIV exposed children in the first district-wide programme using extended regimens for the prevention of mother-to-child transmission of HIV, in Yaounde, Cameroon.
Njom Nlend AE; Same Ekobo C; Bitoungui M; Bagfegue Ekani B; Tchokoteu P; Lyeb S; Chewa G; Ndiang Tetang Moyo S; Tchendjou Takam P;
J Trop Pediatr; 2012 Aug; 58(4):297-302. PubMed ID: 22210553
[TBL] [Abstract][Full Text] [Related]
4. Protecting the next generation--eliminating perinatal HIV-1 infection.
Mofenson LM
N Engl J Med; 2010 Jun; 362(24):2316-8. PubMed ID: 20554987
[No Abstract] [Full Text] [Related]
5. Is Option B+ the best choice?
Coutsoudis A; Goga A; Desmond C; Barron P; Black V; Coovadia H
Lancet; 2013 Jan; 381(9863):269-71. PubMed ID: 23351797
[No Abstract] [Full Text] [Related]
6. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
[TBL] [Abstract][Full Text] [Related]
7. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
[TBL] [Abstract][Full Text] [Related]
8. HAART during pregnancy and during breastfeeding among HIV-infected women in the developing world: has the time come?
Bulterys M; Wilfert CM
AIDS; 2009 Nov; 23(18):2473-7. PubMed ID: 19838097
[No Abstract] [Full Text] [Related]
9. Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.
French CE; Tookey PA; Cortina-Borja M; de Ruiter A; Townsend CL; Thorne C
Antivir Ther; 2013; 18(2):183-92. PubMed ID: 23475123
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
11. Coverage of highly active antiretroviral therapy among postpartum women in Malawi.
Kumwenda J; Matchere F; Mataya R; Chen S; Mipando L; Li Q; Kumwenda NI; Taha TE
Int J STD AIDS; 2011 Jul; 22(7):368-72. PubMed ID: 21729953
[TBL] [Abstract][Full Text] [Related]
12. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso.
Kouanda S; Tougri H; Cisse M; Simpore J; Pietra V; Doulougou B; Ouedraogo G; Ouedraogo CM; Soudre R; Sondo B
AIDS Care; 2010 Jul; 22(7):843-50. PubMed ID: 20635248
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.
Coovadia H
N Engl J Med; 2004 Jul; 351(3):289-92. PubMed ID: 15247337
[No Abstract] [Full Text] [Related]
14. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
Palacios R; Senise J; Vaz M; Diaz R; Castelo A
HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
[TBL] [Abstract][Full Text] [Related]
15. Preconception antiretroviral therapy and birth defects: what is needed?
Bulterys M; Berry RJ; Watts DH
AIDS; 2014 Nov; 28(18):2777-80. PubMed ID: 25493603
[No Abstract] [Full Text] [Related]
16. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
[TBL] [Abstract][Full Text] [Related]
17. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
18. Preliminary assessment of breastfeeding practices in HIV 1-infected mothers (prior to weaning) under the Djoungolo programme on the prevention of mother-to-child transmission of HIV.
Nlend AE; Ekani BB
J Trop Pediatr; 2010 Dec; 56(6):436-9. PubMed ID: 20332220
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
20. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
